Cyclomics, a UMC Utrecht spin-off originating from the research group of Associate Professor Jeroen de Ridder, announced the developer access of a new ‘liquid biopsy’ research workflow using Nanopore sequencing to detect specific molecules associated with cancer circulating in the blood.